Becker's Healthcare December 23, 2024
Paige Twenter

Nearly three years after its launch, Mark Cuban Cost Plus Drug Co. now manufactures injectables in shortage, works with thousands of healthcare facilities, including pharmacies, hospitals, long-term care sites and clinics, and offers more than 2,000 discounted generics and about a dozen branded medicines.

In an email Q&A with Becker’s, Mark Cuban said his pharmaceutical company’s central theme in 2024 has been exponential growth.

“But beyond that,” Mr. Cuban said, “Not much :).”

Cost Plus Drugs’ CEO and co-founder, Alex Oshmyansky, MD, PhD, told Becker’s in June that the company directly works with 38 of the 40 largest generic manufacturers and multiple secondary distributors. These relationships have helped Cost Plus Drugs supply cheaper medications for hundreds of medical...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
The CMS NHE 2023 Report: An Incomplete Picture at a Pivotal Time
Pharma At A Crossroads: Navigating Cost Pressures And Regulatory Shifts In 2025
Q&A: Proposed changes to Social Security Act would recognize pharmacists as healthcare providers
What’s on pharmacy leaders' radars for 2025

Share This Article